• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group.

作者信息

Lechler E, Schramm W, Flosbach C W

机构信息

Department of Internal Medicine, University of Cologne, Germany.

出版信息

Haemostasis. 1996;26 Suppl 2:49-56. doi: 10.1159/000217272.

DOI:10.1159/000217272
PMID:8707167
Abstract

In a multicentre, randomized, double-blind controlled trial comparing the low-molecular-weight heparin enoxaparin (40 mg) with a standard unfractionated heparin (Ca-heparin, 3 x 5,000 U) in deep-vein thrombosis prophylaxis in a high-risk group of 959 hospitalized medical patients, enoxaparin was at least as efficacious as standard heparin, with fewer adverse events.

摘要

相似文献

1
The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group.
Haemostasis. 1996;26 Suppl 2:49-56. doi: 10.1159/000217272.
2
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group.依诺肝素与普通肝素预防择期癌症手术中深静脉血栓形成的疗效和安全性：一项采用静脉造影评估的双盲随机多中心试验。依诺肝素预防癌症手术患者深静脉血栓形成研究组
Br J Surg. 1997 Aug;84(8):1099-103.
3
Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.依诺肝素预防大手术后深静脉血栓形成：多中心研究。意大利研究小组。
Int Surg. 1993 Jul-Sep;78(3):271-5.
4
A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.依诺肝素与普通肝素预防老年急性内科疾病卧床住院患者静脉血栓栓塞性疾病的多中心随机双盲研究。医学依诺肝素研究组。
Thromb Haemost. 1996 Oct;76(4):529-34.
5
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.低分子量肝素与普通肝素治疗不稳定型冠状动脉疾病的比较。皮下注射依诺肝素治疗非Q波冠状动脉事件研究组的疗效与安全性。
N Engl J Med. 1997 Aug 14;337(7):447-52. doi: 10.1056/NEJM199708143370702.
6
The role of low-molecular-weight heparins in the prevention of venous thrombosis in surgery with special reference to enoxaparin.
Haemostasis. 1996;26 Suppl 2:39-48. doi: 10.1159/000217271.
7
Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Enoxaparin Clinical Trial Group.依诺肝素与普通肝素预防择期膝关节置换术后深静脉血栓形成的疗效和安全性。依诺肝素临床试验组。
Clin Orthop Relat Res. 1995 Dec(321):19-27.
8
A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.低分子量肝素、非甾体抗炎药和安慰剂治疗浅静脉血栓形成的一项前瞻性随机双盲对照研究
Arch Intern Med. 2003 Jul 28;163(14):1657-63. doi: 10.1001/archinte.163.14.1657.
9
Prevention of venous thromboembolic risk in non-surgical patients.
Haemostasis. 1996;26 Suppl 2:16-23. doi: 10.1159/000217269.
10
Prevention of deep vein thrombosis after hip replacement--reply.
Thromb Haemost. 2000 Oct;84(4):738-9.

引用本文的文献

1
Systematic review of venous thromboembolism (VTE) occurrence in hospitalized patients receiving prophylactic unfractionated heparin twice vs. three times daily.对接受每日两次与每日三次普通肝素预防性治疗的住院患者静脉血栓栓塞（VTE）发生率的系统评价。
J Thromb Thrombolysis. 2025 Jun 26. doi: 10.1007/s11239-025-03137-8.
2
Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure.慢性阻塞性肺疾病或心力衰竭内科住院患者使用依诺肝素或普通肝素进行血栓预防的有效性、安全性及成本
J Health Econ Outcomes Res. 2024 Feb 20;11(1):44-56. doi: 10.36469/001c.92408. eCollection 2024.
3
Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity.
依诺肝素或普通肝素对肥胖住院患者进行血栓预防的有效性、安全性及成本
Front Cardiovasc Med. 2023 Jun 16;10:1163684. doi: 10.3389/fcvm.2023.1163684. eCollection 2023.
4
Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis.急性住院患者血栓预防用抗凝药物：系统评价和网络荟萃分析。
BMJ. 2022 Jul 4;378:e070022. doi: 10.1136/bmj-2022-070022.
5
Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients.376858 名住院美国内科患者中依诺肝素与未分级肝素预防性使用的真实世界比较有效性和成本比较。
Am J Cardiovasc Drugs. 2021 Jul;21(4):443-452. doi: 10.1007/s40256-020-00456-4. Epub 2020 Dec 14.
6
Role of ambulation to prevent venous thromboembolism in medical patients: where do we stand?活动对预防内科患者静脉血栓栓塞的作用：我们目前的情况如何？
J Vasc Bras. 2019 Jun 25;18:e20180107. doi: 10.1590/1677-5449.180107.
7
Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients.低体重患者静脉血栓栓塞症预防的依诺肝素剂量
Clin Med Insights Blood Disord. 2019 Jul 17;12:1179545X19863814. doi: 10.1177/1179545X19863814. eCollection 2019.
8
Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus.癌症相关血栓形成：超越临床实践指南——多学科（SEMI-SEOM-SETH）专家共识
TH Open. 2018 Nov 5;2(4):e373-e386. doi: 10.1055/s-0038-1675577. eCollection 2018 Oct.
9
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.美国血液学会 2018 年静脉血栓栓塞症管理指南：住院和非住院医疗患者的预防。
Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
10
Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis.医学疾病患者的静脉血栓栓塞预防：混合治疗比较荟萃分析。
J Thromb Thrombolysis. 2018 Jan;45(1):36-47. doi: 10.1007/s11239-017-1562-5.